The IAEA and the Institute for Nuclear Sciences Applied to Health, University of Coimbra, Portugal (POR-ICNAS) have agreed to work together in the area of radioisotopes and radiopharmaceuticals’ production. POR-ICNAS will be the first IAEA collaborating centre in the field of cyclotron radiopharmaceutical production as well as the first one dedicated entirely to the field of radio-pharmacy.
Cyclotrons are important facilities for producing radiopharmaceuticals for non-communicable diseases, in particular for cancers and neurological diseases. Cyclotrons are the main source for the production of positron emitting radioisotopes to be used in the PET technology for diagnosis in nuclear medicine. A large number of IAEA member states are focusing on the installation of facilities for the generation and development of cyclotron-based radiopharmaceuticals. The need for an IAEA collaborating center in this area was the driving force behind the recognition of ICNAS as the 46th IAEA Collaborating Centre.
To read more please visit: